Premium
PROGRESSION‐FREE SURVIVAL FOLLOWING LENALIDOMIDE‐BASED TREATMENT IS SIGNIFICANTLY LONGER IN EXTRAGASTRIC THAN IN GASTRIC MARGINAL ZONE B‐CELL LYMPHOMA OF THE MUCOSA‐ASSOCIATED LYMPHOID TISSUE LYMPHOMA (MALT LYMPHOMA)
Author(s) -
Kiesewetter B.,
Mayerhoefer M.E.,
Dolak W.,
Lukas J.,
SimonitschKlupp I.,
Raderer M.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_77
Subject(s) - medicine , malt lymphoma , gastroenterology , lymphoma , mucosa associated lymphoid tissue , helicobacter pylori , marginal zone b cell lymphoma , rituximab , marginal zone , b cell , immunology , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom